Jpmorgan Chase & Co »

Aldeyra Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $111k 32k 3.51
2023-09-30 $213k 32k 6.68
2023-06-30 $305k 36k 8.38
2023-03-31 $999 73 13.70
2022-12-31 $999 73 13.70
2022-06-30 $0 73 0.00
2022-03-31 $0 23k 0.00
2021-12-31 $75k 19k 4.01
2021-03-31 $999 48 20.83
2020-12-31 $0 48 0.00
2020-09-30 $0 48 0.00
2020-06-30 $14k 3.4k 4.10
2020-03-31 $0 63k 0.00
2019-12-31 $43k 7.4k 5.82
2019-09-30 $181k 34k 5.27
2019-06-30 $38k 6.2k 6.13
2019-03-31 $47k 5.2k 9.12
2018-12-31 $200k 24k 8.32
2018-09-30 $99k 7.2k 13.69
2018-06-30 $509k 63k 8.04
2018-03-31 $446k 60k 7.50
2017-12-31 $338k 50k 6.80
2017-03-31 $6.0k 1.1k 5.45
2016-09-30 $11k 1.4k 7.86
2016-06-30 $1.0k 200 5.00
2015-09-30 $371k 64k 5.83